Novartis' Zortress cleared by FDA for liver transplants PMLiVE Zortress (everolimus) is already approved in the US for preventing organ rejection in kidney transplant patients, and was cleared for the liver transplant indication last year in Europe, where it is sold as Certican and also used in renal and heart ... US FDA approves Novartis' Zortress to prevent organ rejection in adult liver ... FDA grants fresh approval for Novartis' Zortress Novartis Zortress medication wins FDA nod to prevent liver transplantation ... |
